Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Revenue: 2023-2024

Historic Revenue for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $200,000.

  • Inhibrx Biosciences' Revenue was N/A to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.9 million, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2024, which is 88.89% down from last year.
  • According to the latest figures from FY2024, Inhibrx Biosciences' Revenue is $200,000, which was down 88.89% from $1.8 million recorded in FY2023.
  • Over the past 5 years, Inhibrx Biosciences' Revenue peaked at $1.8 million during FY2023, and registered a low of $200,000 during FY2024.
  • Over the past 2 years, Inhibrx Biosciences' median Revenue value was $1.0 million (recorded in 2023), while the average stood at $1.0 million.
  • Data for Inhibrx Biosciences' Revenue shows a maximum YoY tumbled of 88.89% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Revenue stood at $1.8 million in 2023, then crashed by 88.89% to $200,000 in 2024.